Health News Listerine Maker Kenvue Beats Estimates On Strong Essential Health Product Sales

Tylenol Maker Kenvue Misses Sales Estimates Amid Kimberly-Clark's $48.7-Billion Deal

(Reuters) -Kenvue missed Wall Street estimates for third-quarter sales on Monday, while it also announced its acquisition by Kimberly-Clark for about $48.7 billion. The consumer health company's ... Read More

Kimberly-Clark to acquire Tylenol maker Kenvue in $48.7 billion deal

Kimberly-Clark on Monday said it is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, combining the Huggies manufacturer with the owner of Aveeno and Band-Aid. Kenvue ... Read More

Kenvue shares fall even as J&J spinoff beats estimates in first quarterly earnings since IPO

The company, formerly J&J's consumer health division, also issued an upbeat sales outlook for 2023. Kenvue CEO Thibaut Mongon said during an earnings call that the consumer landscape "continues to be ... Read More

Tylenol maker Kenvue misses sales estimates amid Kimberly-Clark's $48.7-billion deal

Last week, U.S. Health and Human Services Secretary Robert F. Kennedy Jr acknowledged there is no evidence proving Tylenol causes autism, but repeated his view that signs of a link between the two ... Read More

Kimberly-Clark will buy Tylenol maker Kenvue in a $48.7 billion deal

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ... Read More

Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ... Read More